Loading...
Adalimumab
India Pharmaceutical Trade Intelligence
Who Supplies Adalimumab to India from SOUTH KOREA
India's adalimumab imports from SOUTH KOREA total $277 across 3 shipments from 2 foreign suppliers. BODITECH MED INC. leads with $157 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BODITECH MED INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for adalimumab — a concentrated sourcing relationship with select suppliers from SOUTH KOREA.
Top foreign suppliers (SOUTH KOREA) — Ranked by import value
BODITECH MED INC. is the leading Adalimumab supplier from SOUTH KOREA to India, with import value of $157 across 1 shipments. The top 5 suppliers — BODITECH MED INC., UNITED STATES PHARMACOPEIAL CONENTION — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SOUTH KOREA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BODITECH MED INC. | $157 | 1 | 56.9% |
| 2 | UNITED STATES PHARMACOPEIAL CONENTION | $119 | 2 | 43.1% |
Showing top 2 of 2 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from SOUTH KOREA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BODITECH MED INDIA PRIVATE LIMITED | $157 | 1 | 56.9% |
| 2 | UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED | $119 | 2 | 43.1% |
Import Statistics
- Import Value
- $277
- Shipments
- 3
- Foreign Suppliers
- 2
- Indian Buyers
- 2
- Avg. Shipment
- $92
Other Adalimumab Import Origins
Related Analysis
Frequently Asked Questions — Adalimumab Imports from SOUTH KOREA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Adalimumab suppliers from SOUTH KOREA to India?
The top Adalimumab suppliers from SOUTH KOREA to India include BODITECH MED INC., UNITED STATES PHARMACOPEIAL CONENTION. The leading supplier is BODITECH MED INC. with import value of $157 USD across 1 shipments. India imported Adalimumab worth $277 USD from SOUTH KOREA in total across 3 shipments.
QHow much Adalimumab does India import from SOUTH KOREA?
India imported Adalimumab worth $277 USD from SOUTH KOREA across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Adalimumab from SOUTH KOREA?
The main Indian buyers of Adalimumab sourced from SOUTH KOREA include BODITECH MED INDIA PRIVATE LIMITED, UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED. The largest buyer is BODITECH MED INDIA PRIVATE LIMITED with $157 in imports across 1 shipments.
QWhat is the total value of Adalimumab imports from SOUTH KOREA to India?
The total value of Adalimumab imports from SOUTH KOREA to India is $277 USD, across 3 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: SOUTH KOREA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Adalimumab.
- 2.Supplier/Buyer Matching: 2 foreign suppliers from SOUTH KOREA and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $277 aggregated from 3 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists